Delivery Order SPE2DB24D1205-SPE2DB25FCWAB
Award Date
4/21/25
Potential Completion Date
4/22/25
Potential Value
$8.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $2,920.86 and is a firm fixed-price delivery order with a completion date of February 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $7,753.70 and a completion date of February 29, 2024. The contract is a firm fixed-price delivery order, with no set-aside requirements indicated. AmerisourceBergen also holds a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,702,158 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $12,654.97 and a completion date of March 27, 2025. The contract is not designated as a set-aside....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,828,704 units of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $19,733.40 and a completion date of April 8, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,567,320 units of Ondansetron ODT 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $2,154.60 and is a firm fixed-price delivery order, with a completion date of February 21, 2025. This contract is a part of a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,980.59, is for the supply of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a period of performance through March 28, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of Ondansetron HCL 4 MG Tablet, a medication used to treat nausea and vomiting. The contract has a ceiling value of $24,183.47 and is a firm fixed-price, delivery order contract. The ultimate completion date is December 1, 2022. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award, valued at $12,458.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,678 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of March 25, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition....
This federal contract award, valued at $2,919.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, which are used to treat nausea and vomiting. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $1,970.57 and is a firm fixed-price delivery order with a completion date of March 19, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...